Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LISOCABTAGENE MARALEUCEL vs LOPERAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LISOCABTAGENE MARALEUCEL vs LOPERAMIDE: Safety Overview

Metric LISOCABTAGENE MARALEUCEL LOPERAMIDE
Total FAERS Reports 738 18,011
Deaths Reported 132 1,551
Death Rate 17.9% 8.6%
Hospitalizations 396 4,298
Average Patient Age 66.3 yrs 58.9 yrs
% Female Patients 36.8% 64.3%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Juno Therapeutics, Inc. Chain Drug Consortium
Route N/A ORAL
Marketing Status N/A Discontinued